Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Fantin

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
The Journal of Hospital Infection|July 17, 2018
Faecal microbiota transplantation with frozen capsules for relapsing Clostridium difficile infections: the first experience from 15 consecutive patients in FranceG Cheminet, N Kapel, A Bleibtreu, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1990
Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamaseB Fantin, B Pangon, G Potel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 24, 2010
Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical featuresA Courpon-Claudinon, A Lefort, X Panhard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2000
Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipientsF Bert, J O Galdbart, V Zarrouk, et al.
Annales De Dermatologie Et De Venereologie|September 30, 2018
[The value of fecal calprotectin assay in chronic panniculitis of unknown etiology]K Kaddour, J Lemasson, B Haettich-Pialoux, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1991
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlationG Potel, J Caillon, B Fantin, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2026
Temocillin efficacy and emergence of resistance in Enterobacter cloacae Complex in a murine peritonitis modelN Alanbari, A Amoura, F Guérin, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia modelE Azoulay-Dupuis, J P Bédos, J Mohler, et al.
International Journal of Medical Microbiology : IJMM|January 14, 2022
Evolution of fluoroquinolone-resistant Escherichia coli in the gut after ciprofloxacin treatmentV de Lastours, I El Meouche, F Chau, et al.
International Journal of Antimicrobial Agents|June 11, 2023
Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infectionsT Goulenok, J Seurat, A de La Selle, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
The Journal of Hospital Infection|July 17, 2018
Faecal microbiota transplantation with frozen capsules for relapsing Clostridium difficile infections: the first experience from 15 consecutive patients in FranceG Cheminet, N Kapel, A Bleibtreu, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1990
Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamaseB Fantin, B Pangon, G Potel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 24, 2010
Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical featuresA Courpon-Claudinon, A Lefort, X Panhard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2000
Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipientsF Bert, J O Galdbart, V Zarrouk, et al.
Annales De Dermatologie Et De Venereologie|September 30, 2018
[The value of fecal calprotectin assay in chronic panniculitis of unknown etiology]K Kaddour, J Lemasson, B Haettich-Pialoux, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1991
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlationG Potel, J Caillon, B Fantin, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2026
Temocillin efficacy and emergence of resistance in Enterobacter cloacae Complex in a murine peritonitis modelN Alanbari, A Amoura, F Guérin, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia modelE Azoulay-Dupuis, J P Bédos, J Mohler, et al.
International Journal of Medical Microbiology : IJMM|January 14, 2022
Evolution of fluoroquinolone-resistant Escherichia coli in the gut after ciprofloxacin treatmentV de Lastours, I El Meouche, F Chau, et al.
International Journal of Antimicrobial Agents|June 11, 2023
Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infectionsT Goulenok, J Seurat, A de La Selle, et al.
Pageof 12